Cargando…
Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies?
SIMPLE SUMMARY: It is now thought that bacteria in the gut and tumour of patients with pancreatic cancer play an important role in the growth of the cancer and its sensitivity to chemotherapy. It has been shown that pancreatic exocrine insufficiency (PEI), common in pancreatic cancer patients, is li...
Autores principales: | Halle-Smith, James M., Hall, Lewis A., Powell-Brett, Sarah F., Merali, Nabeel, Frampton, Adam E., Beggs, Andrew D., Moss, Paul, Roberts, Keith J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649877/ https://www.ncbi.nlm.nih.gov/pubmed/37958314 http://dx.doi.org/10.3390/cancers15215140 |
Ejemplares similares
-
Pancreatic exocrine insufficiency after pancreaticoduodenectomy: Current evidence and management
por: Pathanki, Adithya M, et al.
Publicado: (2020) -
Pancreatic Exocrine Insufficiency in Pancreatic Cancer
por: Vujasinovic, Miroslav, et al.
Publicado: (2017) -
Casting a Wider NET: Pancreatic Exocrine Insufficiency Induced by Somatostatin Analogues among Patients with Neuroendocrine Tumours?
por: Hall, Lewis A., et al.
Publicado: (2023) -
Less common etiologies of exocrine pancreatic insufficiency
por: Singh, Vikesh K, et al.
Publicado: (2017) -
Challenges in the management of pancreatic exocrine insufficiency
por: Shandro, Benjamin Myles, et al.
Publicado: (2018)